THE EFFECT OF ORAL BASES ON ENTERAL ALUMINUM ABSORPTION

被引:31
作者
WALKER, JA [1 ]
SHERMAN, RA [1 ]
CODY, RP [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT ENVIRONM & COMMUNITY MED,NEW BRUNSWICK,NJ 08903
关键词
D O I
10.1001/archinte.150.10.2037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Physicochemical considerations suggest that citrate may potentiate gastrointestinal aluminum absorption via the formation of an aluminum citrate moiety. We tested this hypothesis and also studied whether sodium bicarbonate would have a similar effect. Eight healthy adults each partook of four oral regimens: aluminum alone, aluminum plus sodium bicarbonate, aluminum plus citrate (as Shohl's solution), and citrate alone. Twenty-four hour urine collections were obtained immediately preceeding and during the second day of each medication period for determination of aluminum content. A significant but similar increment in urinary aluminum occurred with both aluminum alone and aluminum plus sodium bicarbonate, while only a small increment was noted with Shohl's solution alone. The rise in urinary aluminum obtained with aluminum plus Shohl's solution, however, was nearly eight times that seen with either aluminum alone or aluminum plus sodium bicarbonate (327 μg vs 45 μg and 41 μg, respectively). Citrate thus appears to augment gastrointestinal aluminum absorption markedly, an effect not shared by an equivalent dose of sodium bicarbonate. Citrate administration to patients with renal failure who are also taking aluminum-containing medication may be harmful.
引用
收藏
页码:2037 / 2039
页数:3
相关论文
共 38 条
[1]  
ALFREY AC, 1986, KIDNEY INT S18, V29, pS8
[2]  
ANDERSEN JR, 1987, TRACE ELEM MED, V4, P42
[3]  
BAKIR AA, 1986, T AM SOC ART INT ORG, V32, P171
[4]  
BERLYNE GM, 1972, LANCET, V1, P564
[5]  
BERLYNE GM, 1970, LANCET, V2, P494
[6]   ALUMINUM - ANALYTICAL CONSIDERATIONS [J].
BURNATOWSKAHLEDIN, M ;
MAYOR, GH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1985, 6 (05) :283-287
[7]  
CANNATA JB, 1984, P EUR DIAL TRANSPLAN, V21, P354
[8]  
COCHRAN M, 1985, CLIN CHEM, V31, P1314
[9]   VITAMIN-D TREATMENT - A HIDDEN RISK FACTOR FOR ALUMINUM BONE TOXICITY [J].
COLUSSI, G ;
ROMBOLA, G ;
DEFERRARI, ME ;
MINOLA, E ;
MINETTI, L .
NEPHRON, 1987, 47 (01) :78-80
[10]   ALUMINUM LOCALIZATION IN BONE FROM HEMODIALYZED PATIENTS - RELATIONSHIP TO MATRIX MINERALIZATION [J].
COURNOTWITMER, G ;
ZINGRAFF, J ;
PLACHOT, JJ ;
ESCAIG, F ;
LEFEVRE, R ;
BOUMATI, P ;
BOURDEAU, A ;
GARABEDIAN, M ;
GALLE, P ;
BOURDON, R ;
DRUEKE, T ;
BALSAN, S .
KIDNEY INTERNATIONAL, 1981, 20 (03) :375-385